Mon, December 5, 2022

Andrew Fein Maintained (STOK) at Strong Buy with Decreased Target to $35 on, Dec 5th, 2022

Andrew Fein of HC Wainwright & Co., Maintained "Stoke Therapeutics, Inc." (STOK) at Strong Buy with Decreased Target from $70 to $35 on, Dec 5th, 2022.

Andrew has made no other calls on STOK in the last 4 months.



There are 2 other peers that have a rating on STOK. Out of the 2 peers that are also analyzing STOK, 0 agree with Andrew's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Andrew


  • Judah Frommer of "Credit Suisse" Maintained at Buy with Decreased Target to $38 on, Tuesday, November 15th, 2022
  • Joseph Stringer of "Needham" Maintained at Strong Buy with Decreased Target to $25 on, Monday, November 14th, 2022